Cited by 397Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsSirtuins and Resveratrol in Medicine

The DOI matches its Crossref record; 370 of the 375 references it cites were found in a registry or an index; none of the 530 sources its claims cite is checked for support yet.

Mechanisms and Regulation of Cellular Senescence

Open access
Roger, Lauréline, Tomas, Fanny, Gire, Véronique·2021·International Journal of Molecular Sciences

Abstract

Cellular senescence entails a state of an essentially irreversible proliferative arrest in which cells remain metabolically active and secrete a range of pro-inflammatory and proteolytic factors as part of the senescence-associated secretory phenotype. There are different types of senescent cells, and senescence can be induced in response to many DNA damage signals. Senescent cells accumulate in different tissues and organs where they have distinct physiological and pathological functions. Despite this diversity, all senescent cells must be able to survive in a nondividing state while protecting themselves from positive feedback loops linked to the constant activation of the DNA damage response. This capacity requires changes in core cellular programs. Understanding how different cell types can undergo extensive changes in their transcriptional programs, metabolism, heterochromatin patterns, and cellular structures to induce a common cellular state is crucial to preventing cancer development/progression and to improving health during aging. In this review, we discuss how senescent cells continuously evolve after their initial proliferative arrest and highlight the unifying features that define the senescent state.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review synthesizes mechanisms and regulation of cellular senescence, emphasizing heterogeneity, cell-cycle arrest via p53/p21 and p16/RB, the SASP, metabolic/chromatin changes, and positive feedback loops. It discusses senescence’s dual roles in cancer and aging and therapeutic implications including senolytics.

Key findings

  • Senescence is an essentially irreversible proliferative arrest with continued metabolic activity and a SASP; cell-cycle exit can occur in G1 or G2, with p53/p21 as early markers and p16/ARF as late markers. Acute DNA damage can trigger rapid exit within 24 h, and the G2/M checkpoint responds to 10–20 DNA breaks.
  • Replicative senescence is driven by telomere erosion; mean telomere length in human senescent fibroblasts ranges between 6 and 8 kbp, with a few extremely short telomeres. Persistent DDR at telomeres, partly because TRF2 blocks repair, sustains arrest.
  • The SASP is regulated by NF-κB/C/EBP-β, ATM, p38MAPK, GATA4, mTOR, epigenetic factors, and cGAS–STING signaling; it can reinforce senescence and drive inflammaging and paracrine senescence.
  • Senescence has dual roles: it acts as a barrier to tumorigenesis, but SASP factors can promote cancer progression; senescent cell accumulation contributes to aging, and clearance via senolytics or INK-ATTAC alleviates age-related dysfunction and extends healthspan in mice.

Methods

  • Narrative review; no primary experiments. It synthesizes published literature on mammalian cellular senescence mechanisms, regulation, and roles in cancer and aging.
  • Covers in vitro and in vivo studies, including mouse models, human cells/tissues, and clinical observations; main analysis is thematic synthesis of signaling pathways, transcriptional/post-transcriptional control, metabolism, organelles, autophagy, epigenetics, and immune clearance.
  • No systematic search or meta-analysis is described.

Limitations

  • Stated: lack of specific biomarkers to identify and follow senescent cells in vivo; much knowledge comes from cultured cells that do not recapitulate organism complexity; findings need in vivo confirmation; heterogeneity complicates assigning exact roles.
  • Stated: it remains challenging to study how senescent cells are induced in vivo, how the SASP changes over time, when the SASP acquires damaging traits, and how senescent cell clearance is regulated.
  • Evident: as a narrative review, it does not provide a systematic or quantitative synthesis and reports no primary data to assess causality.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms222313173

Cites

370 of 370 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 530 cited sources checked · 0 supported · 0 flagged

Show all 271 claims

  • It may state two separate claims as one. 114
  • Probably not a substantial claim. 12
123 of 123
  • The paper relies on this without support.

    The G2/M checkpoint only responds to 10–20 DNA breaks.

    “This threshold number is not a single DNA break because the G2/M checkpoint only responds to 10–20 DNA breaks.”
  • The paper relies on this without support.

    Endogenous expression levels of oncogenes are unlikely to cause OIS.

    “As the endogenous expression levels of oncogenes are unlikely to cause OIS, the stochastic accumulation of mutations might be needed for OIS induction [118].”
  • The paper relies on this without support.

    Cancer cells must replicate to produce a macroscopic tumor.

    “because cancer cells must replicate to produce a macroscopic tumor.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • cGAS product conflicts with the enzyme name given

    Minor

    The text identifies cGAS as cyclic GMP-AMP synthase but then says it produces cGMP, a different molecule.

1 of 1

Citations

Cites

Flagged first, then by citations

Show all 375 references

5 of the 375 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 201–300 of 397

Metadata

Authors
Roger, L., Tomas, F., & Gire, V.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Gire, Véronique
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-12-06
Volume
22
Issue
23
Pages
13173
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4200606392
Cited by
395
References
375
Citations by year
2026: 65 · 2025: 139 · 2024: 90 · 2023: 69 · 2022: 31 · 2021: 1
FWCI
6.48
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
cellular senescence, senescence-associated secretory phenotype, DNA damage response, proliferative arrest, senescence induction, senescence heterogeneity, senescence-associated inflammation, heterochromatin, cellular metabolism, transcriptional programs, aging, cancer prevention
MeSH terms
Senescence-Associated Secretory Phenotype, Aging, Animals, DNA Damage, Humans, Inflammation, Signal Transduction, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review